Literature DB >> 7525191

Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment.

A N Nafziger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7525191     DOI： 10.2165/00003495-199448010-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  49 in total

1.  Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah.

Authors:  R R Williams; P N Hopkins; S C Hunt; L L Wu; S J Hasstedt; J M Lalouel; K O Ash; B M Stults; H Kuida
Journal:  Arch Intern Med       Date:  1990-03

2.  Over 80 years and no evidence of coronary heart disease: characteristics of a survivor group.

Authors:  A J Campbell; W J Busby; M C Robertson
Journal:  J Am Geriatr Soc       Date:  1993-12       Impact factor: 5.562

3.  Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study.

Authors:  L A Carlson; L E Böttiger
Journal:  Acta Med Scand       Date:  1985

4.  Plasma lipoprotein levels as predictors of cardiovascular death in women.

Authors:  K M Bass; C J Newschaffer; M J Klag; T L Bush
Journal:  Arch Intern Med       Date:  1993-10-11

Review 5.  Effects of exercise training on glucose control, lipid metabolism, and insulin sensitivity in hypertriglyceridemia and non-insulin dependent diabetes mellitus.

Authors:  R M Lampman; D E Schteingart
Journal:  Med Sci Sports Exerc       Date:  1991-06       Impact factor: 5.411

6.  Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.

Authors:  C J Mann; F T Yen; A M Grant; B E Bihain
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

7.  Effects of noninsulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages.

Authors:  F B Kraemer; Y D Chen; R D Lopez; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1985-08       Impact factor: 5.958

8.  Familial aggregation of lipids and lipoproteins and early identification of dyslipoproteinemia. The Collaborative Lipid Research Clinics Family Study.

Authors:  J A Morrison; K Namboodiri; P Green; J Martin; C J Glueck
Journal:  JAMA       Date:  1983-10-14       Impact factor: 56.272

9.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

10.  Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes.

Authors:  K Hiramatsu; S Arimori
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461
View more
  2 in total

1.  Effect of low HDL combined with hypertriglyceridemia in coronary artery disease patients on PGI2 biological activity in relation to lipid regulating treatment.

Authors:  J Li; G Dai; Z Feng; C Wang; Y Yang; W Wei; B Zhou
Journal:  J Tongji Med Univ       Date:  1998

Review 2.  Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.

Authors:  K L Goa; L B Barradell; G L Plosker
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.